YD Bio Ltd (YDES) stock
YDESNasdaqServices-Medical LaboratoriesFiscal year ends December 31Also trades as YDESW
$4.73−0.10 (-2.07%)
Close on Nov 17, 2026Market cap $334.83MP/E –Yield –
YD Bio r&d expenses
Research and development expenses are spending on new products and technology.
For fiscal 2025 it was $1.60M, up 226.1% from the year before.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.60M | +226.1% |
| FY2024 | Dec 31, 2024 | $491.35K | – |
See a number that looks wrong?